Foe Drug Makers - QuikReader

Pizza chain sparks protests for doubling down on dessert referring to ex-Mayor Marion Barry and drug use

Protesters are demanding an apology and a D.C. pizza shop has been vandalized amid the controversy over &pizza’s ad campaign that makes light of the late Mayor Marion Barry’s drug use.

D.C. pizza chain sparks protests for doubling down on ex-mayor's drug use

Protesters are demanding an apology and a D.C. pizza shop was vandalized for an ad campaign making light of the late Mayor Marion Barry’s drug use. &Pizza promoted a dessert called Marion Berry ...

Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in diabetes patients.

Business - CNBC - October 24

Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...

Business - MarketWatch - October 24

Olympus shares drop over 5% after CEO resigns over drug allegation

The stock slid 5.3% on the Tokyo Stock Exchange following news of Stefan Kaufmann's resignation.

Business - CNBC - October 28

‘People didn’t believe Africa could be a source of innovation’: how the continent holds the key to future drug research

Prof Kelly Chibale says the world is failing to take advantage of African genetic diversity, and everyone could be losing out. Africa has the greatest variety in human genes anywhere on the planet ...

World - The Guardian - October 28

How can we help stop deadly drug-resistant infections spreading? Debt relief | Glenda Gray

Millions of lives could be saved if the world would only consider more innovative ways to help poorer nations tackle AMR. Drug-resistant infection, already one of the world’s biggest killers, is ...

World - The Guardian - October 29

Dozens jailed in drug smuggling mega-trial: "Your honor, I played, I lost."

The multinational cocaine and cannabis trafficking enterprise was busted after investigators cracked encrypted messaging apps.

Anti-aging enthusiasts are turning to the drug rapamycin to help extend their lives—can it work? A longevity doctor weighs in

Longevity seekers are taking rapamycin in hopes of living longer. Here's what a health and longevity doctor has to say about the drug.

Business - CNBC - October 29

Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.

Business - CNBC - October 30

Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.

Business - CNBC - October 30

This retirement expert saved her mom $1,200 on Medicare drugs — and she’s got advice for you, too

It took many frustrating years for Marcia Mantell to convince her mom to let her help.

Business - MarketWatch - 4 days ago

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Business - MarketWatch - October 30

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.

Business - CNBC - 6 days ago

Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

The pharmaceutical giant also raised its full-year revenue forecast to an increase of roughly 5%.

Business - CNBC - 6 days ago

EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for ...

World - ABC News - 6 days ago

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug